Viewing Study NCT02339532


Ignite Creation Date: 2025-12-24 @ 9:40 PM
Ignite Modification Date: 2026-03-29 @ 11:50 AM
Study NCT ID: NCT02339532
Status: COMPLETED
Last Update Posted: 2024-11-08
First Post: 2014-12-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Phase II Trial in Patients With T1c Operable, HER2-positive Breast Cancer According to TOP2A Status
Sponsor: UNICANCER
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module